Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives / Q000494:pharmacology*; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D005263:Femoral Artery / Q000187:drug effects; D006220:Haloperidol / Q000494:pharmacology; D007668:Kidney / Q000098:blood supply*; D008638:Mesenteric Arteries / Q000187:drug effects*; D009284:Naphthols / Q000494:pharmacology*; D011955:Receptors, Drug; D012039:Regional Blood Flow / Q000187:drug effects; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents
D009284:Naphthols; D011955:Receptors, Drug; D014665:Vasodilator Agents; C009074:N-n-propylnorapomorphine; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine